Literature DB >> 25819105

Spreading depolarizations mediate excitotoxicity in the development of acute cortical lesions.

Jason M Hinzman1, Vince A DiNapoli2, Eric J Mahoney3, Greg A Gerhardt4, Jed A Hartings2.   

Abstract

Spreading depolarizations (SD) are mass depolarizations of neurons and astrocytes that occur spontaneously in acute brain injury and mediate time-dependent lesion growth. Glutamate excitotoxicity has also been extensively studied as a mechanism of neuronal injury, although its relevance to in vivo pathology remains unclear. Here we hypothesized that excitotoxicity in acute lesion development occurs only as a consequence of SD. Using glutamate-sensitive microelectrodes, we found that SD induced by KCl in normal rat cortex elicits increases in extracellular glutamate (11.6±1.3μM) that are synchronous with the onset, sustainment, and resolution of the extracellular direct-current shift of SD. Inhibition of glutamate uptake with d,l-threo-β-benzyloxyaspartate (TBOA, 0.5 and 1mM) significantly prolonged the duration of the direct-current shift (148% and 426%, respectively) and the glutamate increase (167% and 374%, respectively) in a dose-dependent manner (P<0.05). These prolonged events produced significant cortical lesions as indicated by Fluoro-Jade staining (P<0.05), while no lesions were observed after SD in control conditions or after cortical injection of 1mM glutamate (extracellular increase: 243±50.8μM) or 0.5mM TBOA (glutamate increase: 8.5±1.6μM) without SD. We then used an embolic focal ischemia model to determine whether glutamate elevations occur independent of SD in the natural evolution of a cortical lesion. In both the ischemic core and penumbra, glutamate increased only in synchrony with anoxic terminal SD (6.1±1.1μM) and transient SDs (11.8±2.4μM), and not otherwise. Delayed terminal SDs were also observed in two animals at 98 and 150min after ischemic onset and induced similar glutamate elevations. Durations of SDs and glutamate increases were significantly correlated in both normal and ischemic animals (P<0.05). These data suggest that pathologically prolonged SDs are a required mechanism of acute cortical lesion development and that glutamate elevations and the mass electrochemical changes of SD and are merely different facets of the same pathophysiologic process.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Middle cerebral artery occlusion; Spreading depression; Stroke

Mesh:

Substances:

Year:  2015        PMID: 25819105     DOI: 10.1016/j.expneurol.2015.03.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  44 in total

1.  An implantable multimodal sensor for oxygen, neurotransmitters, and electrophysiology during spreading depolarization in the deep brain.

Authors:  Caddy N Hobbs; Justin A Johnson; Matthew D Verber; R Mark Wightman
Journal:  Analyst       Date:  2017-08-07       Impact factor: 4.616

Review 2.  'Spreading depression of Leão' and its emerging relevance to acute brain injury in humans.

Authors:  Martin Lauritzen; Anthony J Strong
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 3.  Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology.

Authors:  Vladimir Parpura; Elizabeth S Fisher; James D Lechleiter; Arne Schousboe; Helle S Waagepetersen; Sylvain Brunet; Selva Baltan; Alexei Verkhratsky
Journal:  Neurochem Res       Date:  2016-02-25       Impact factor: 3.996

4.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

5.  Real-time monitoring of extracellular adenosine using enzyme-linked microelectrode arrays.

Authors:  Jason M Hinzman; Justin L Gibson; Ryan D Tackla; Mark S Costello; Jason J Burmeister; Jorge E Quintero; Greg A Gerhardt; Jed A Hartings
Journal:  Biosens Bioelectron       Date:  2015-07-07       Impact factor: 10.618

6.  Direct current electrocorticography for clinical neuromonitoring of spreading depolarizations.

Authors:  Jed A Hartings; Chunyan Li; Jason M Hinzman; C William Shuttleworth; Griffin L Ernst; Jens P Dreier; J Adam Wilson; Norberto Andaluz; Brandon Foreman; Andrew P Carlson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 7.  The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacy.

Authors:  Jed A Hartings; C William Shuttleworth; Sergei A Kirov; Cenk Ayata; Jason M Hinzman; Brandon Foreman; R David Andrew; Martyn G Boutelle; K C Brennan; Andrew P Carlson; Markus A Dahlem; Christoph Drenckhahn; Christian Dohmen; Martin Fabricius; Eszter Farkas; Delphine Feuerstein; Rudolf Graf; Raimund Helbok; Martin Lauritzen; Sebastian Major; Ana I Oliveira-Ferreira; Frank Richter; Eric S Rosenthal; Oliver W Sakowitz; Renán Sánchez-Porras; Edgar Santos; Michael Schöll; Anthony J Strong; Anja Urbach; M Brandon Westover; Maren Kl Winkler; Otto W Witte; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 8.  The role of oligodendrocytes and their progenitors on neural interface technology: A novel perspective on tissue regeneration and repair.

Authors:  Steven M Wellman; Franca Cambi; Takashi Dy Kozai
Journal:  Biomaterials       Date:  2018-08-22       Impact factor: 12.479

Review 9.  Traumatic brain injury-induced autoregulatory dysfunction and spreading depression-related neurovascular uncoupling: Pathomechanisms, perspectives, and therapeutic implications.

Authors:  Peter Toth; Nikolett Szarka; Eszter Farkas; Erzsebet Ezer; Endre Czeiter; Krisztina Amrein; Zoltan Ungvari; Jed A Hartings; Andras Buki; Akos Koller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-09       Impact factor: 4.733

10.  Chemogenetics-mediated acute inhibition of excitatory neuronal activity improves stroke outcome.

Authors:  Ya-Chao Wang; Francesca Galeffi; Wei Wang; Xuan Li; Liping Lu; Huaxin Sheng; Ulrike Hoffmann; Dennis A Turner; Wei Yang
Journal:  Exp Neurol       Date:  2020-01-18       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.